ASMPT Limited (ASMVY) Research

ASMPT Limited functions as an investment holding enterprise, globally focused on the development, production, and sale of advanced machinery, specialized tools, and crucial materials for the semiconductor and electronics assembly sectors. Its operations are bifurcated into two primary divisions: Semiconductor Solutions and Surface Mount Technology Solutions. The company provides a wide array of equipment for various semiconductor processes, spanning from deposition and wafer separation to automated optical inspection (AOI/FOL), die attachment, wire bonding, dispensing, and encapsulation, alongside solutions for CMOS image sensors (CIS). Additionally, it delivers systems for singulation, trimming, forming, LED testing, sorting, taping, sintering, and complete test and finish handling. Beyond its hardware offerings, ASMPT furnishes cutting-edge technological solutions such as surface mount technologies (SMT), advanced packaging, encapsulation, and specialized platforms for Micro-Electro-Mechanical Systems (MEM), power, LED/opto, and photonics. Its expertise further extends to Chip-on-Board (COB) and stacked die configurations, intelligent SMT factory solutions, and image sensor applications. The company also offers supplementary agency and logistics services. Founded in 1975, ASMPT Limited, headquartered in Tsing Yi, Hong Kong, was previously known as ASM Pacific Technology Limited before officially changing its name in June 2022.

Market snapshot

Symbol
ASMVY
Price
$80.46
Day change
+1.23%
Market cap
$87.6B
P/E ratio
63.58x
52-week range
20.845-81.03
Sector
Technology
Industry
Semiconductors

Peer companies

  • ams-OSRAM AG (AUKUF)
  • freee K.K. (FREKF)
  • OVH Groupe S.A. (OVHFF)
  • Oxford Instruments plc (OXINF)
  • Shanghai Fudan Microelectronics Group Company Limited (SFDMY)
  • Silex Systems Limited (SILXF)
  • Silex Systems Limited (SILXY)
  • Soitec S.A. (SLOIY)

Open ASMPT Limited (ASMVY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.